FY2023 Earnings Forecast for American Healthcare REIT, Inc. Issued By KeyCorp (NYSE:AHR)

American Healthcare REIT, Inc. (NYSE:AHRFree Report) – Equities research analysts at KeyCorp issued their FY2023 earnings per share (EPS) estimates for American Healthcare REIT in a note issued to investors on Sunday, March 3rd. KeyCorp analyst A. Wurschmidt forecasts that the company will post earnings per share of $1.23 for the year. KeyCorp has a “Overweight” rating and a $16.00 price target on the stock. KeyCorp also issued estimates for American Healthcare REIT’s Q4 2023 earnings at $0.29 EPS, Q1 2024 earnings at $0.31 EPS, Q2 2024 earnings at $0.30 EPS, Q3 2024 earnings at $0.31 EPS, Q4 2024 earnings at $0.30 EPS, FY2024 earnings at $1.14 EPS, Q1 2025 earnings at $0.32 EPS, Q2 2025 earnings at $0.33 EPS, Q3 2025 earnings at $0.33 EPS, Q4 2025 earnings at $0.32 EPS and FY2025 earnings at $1.30 EPS.

A number of other equities research analysts have also recently issued reports on the company. Morgan Stanley assumed coverage on American Healthcare REIT in a research note on Monday. They issued an “overweight” rating and a $17.00 target price on the stock. Truist Financial assumed coverage on American Healthcare REIT in a report on Monday. They set a “buy” rating and a $17.00 price target on the stock. JMP Securities assumed coverage on American Healthcare REIT in a report on Monday. They set a “mkt outperform” rating and a $16.00 price target on the stock. Bank of America assumed coverage on American Healthcare REIT in a report on Monday. They set a “buy” rating and a $15.00 price target on the stock. Finally, Royal Bank of Canada assumed coverage on American Healthcare REIT in a report on Monday. They set an “outperform” rating and a $15.00 price target on the stock. One equities research analyst has rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $15.71.

Get Our Latest Stock Analysis on American Healthcare REIT

American Healthcare REIT Price Performance

AHR stock opened at $13.82 on Wednesday. American Healthcare REIT has a 1 year low of $12.63 and a 1 year high of $14.56.

Insider Buying and Selling

In other news, Director Mathieu B. Streiff bought 83,333 shares of the stock in a transaction that occurred on Friday, February 9th. The shares were purchased at an average cost of $12.00 per share, with a total value of $999,996.00. Following the completion of the acquisition, the director now directly owns 90,740 shares in the company, valued at $1,088,880. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink.

About American Healthcare REIT

(Get Free Report)

Formed by the successful merger of Griffin-American Healthcare REIT III and Griffin-American Healthcare REIT IV, as well as the acquisition of the business and operations of American Healthcare Investors, American Healthcare REIT is one of the larger healthcare-focused real estate investment trusts globally with assets totaling approximately $4.2 billion in gross investment value.

Featured Articles

Earnings History and Estimates for American Healthcare REIT (NYSE:AHR)

Receive News & Ratings for American Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for American Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.